Adipose Tissue and Bone Marrow as Sources for Cell-based Therapeutic Angiogenesis in Ischemic Tissues: Biological Foundation and Clinical Prospects for Age-related Vascular Disease
It is well established that aging is a significant risk factor for homeostatic imbalance, decline in vascular regenerative capacity and development of vascular disease with progressive organ dysfunction. Over the past decade therapeutic developments have improved the prognosis for those with vascular disease, mortality rates have nevertheless remained actually unchanged. Clearly, there is a need for alternative strategies for the treatment of vascular disease. Adipose tissue and bone marrow have been shown to contain adult mesenchymal stem cells that have therapeutic applications in regenerative medicine. In vivo experiments suggest that these cells are capable of replacing ischemic damaged tissues. The potential use of cell-based therapeutic angiogenesis has been proposed as an alternative treatment solutions for age-related vascular disease. This review outlines the current knowledge about adipose tissue and bone marrow as a sources of stem and progenitor cells, these cells contribution to ischemic damaged tissues regenerative processes and factors that may affect their decreased function in aging individuals. Moreover, it was described the cell-based therapeutic strategies that are currently being tested in clinical trials as well as clinical outcomes demonstrated after cell transplantation and emphasize possible mechanisms counteracting pathophysiological events of ischemia..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Immunology, endocrine & metabolic agents in medicinal chemistry - 15(2015), 2, Seite 145-159 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bulgin, Dmitry [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC198672106X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC198672106X | ||
| 003 | DE-627 | ||
| 005 | 20230518124703.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170131s2015 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a fidpha_zeitschriften_20170130.pp |
| 035 | |a (DE-627)OLC198672106X | ||
| 035 | |a (DE-599)GBVOLC198672106X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Bulgin, Dmitry |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adipose Tissue and Bone Marrow as Sources for Cell-based Therapeutic Angiogenesis in Ischemic Tissues: Biological Foundation and Clinical Prospects for Age-related Vascular Disease |
| 264 | 1 | |c 2015 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a It is well established that aging is a significant risk factor for homeostatic imbalance, decline in vascular regenerative capacity and development of vascular disease with progressive organ dysfunction. Over the past decade therapeutic developments have improved the prognosis for those with vascular disease, mortality rates have nevertheless remained actually unchanged. Clearly, there is a need for alternative strategies for the treatment of vascular disease. Adipose tissue and bone marrow have been shown to contain adult mesenchymal stem cells that have therapeutic applications in regenerative medicine. In vivo experiments suggest that these cells are capable of replacing ischemic damaged tissues. The potential use of cell-based therapeutic angiogenesis has been proposed as an alternative treatment solutions for age-related vascular disease. This review outlines the current knowledge about adipose tissue and bone marrow as a sources of stem and progenitor cells, these cells contribution to ischemic damaged tissues regenerative processes and factors that may affect their decreased function in aging individuals. Moreover, it was described the cell-based therapeutic strategies that are currently being tested in clinical trials as well as clinical outcomes demonstrated after cell transplantation and emphasize possible mechanisms counteracting pathophysiological events of ischemia. | ||
| 700 | 1 | |a Hodzic, Enes |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunology, endocrine & metabolic agents in medicinal chemistry |d San Francisco, Calif. : Bentham Science Publ., 2006 |g 15(2015), 2, Seite 145-159 |w (DE-627)507526643 |w (DE-600)2221719-8 |w (DE-576)435514261 |x 1871-5222 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2015 |g number:2 |g pages:145-159 |
| 856 | 4 | 0 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1871-5222&volume=15&issue=2&spage=145 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 15 |j 2015 |e 2 |h 145-159 | ||